← Leaderboards
Robert Gyurko
Boston University Medical Campus
$1,853,002
Attributed
$1,853,002
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $411.6K · FY2005–09$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$1,853,002 · 2
By mechanism
R01$1,288,819 · 1
K22$564,183 · 1
Top collaborators
No co-investigators on record.
Most similar at Boston University Medical Campus
Same institution · by research overlap
- Thomas E Van Dyke$23,853,105
- Hatice Hasturk$2,642,133
- Frank G Oppenheim$8,401,221
- Andrew J Henderson$17,448,134
- David Tobin Felson$45,961,276
Others in their field
Top investigators on “Inflammation”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$89,523,713
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Randall J Bateman · Washington University$64,707,456
- Peter Scott Heeger · Case Western Reserve University$56,547,884
Research focus
InflammationSuperoxidesLaboratory MouseEvaluationAnimalsAbbreviationsAnimal ModelDiabetes MellitusApoptosisAspirinAttenuatedBacteriaAlveolar Bone LossBlood GlucoseAnalogAnti-InflammatoryAnti-Inflammatory AgentsCellsCommunicable DiseasesComplications Of Diabetes MellitusCytokineDefensinsDesignAlveolar Bone
Grant awards (9)
In vivo study of diabetic hyperglycemia and inflammation$251,780
R01 · FY2009 · DE · contact PI
In vivo study of diabetic hyperglycemia and inflammation$251,780
R01 · FY2008 · DE · contact PI
In vivo study of diabetic hyperglycemia and inflammation$254,581
R01 · FY2007 · DE · contact PI
In vivo study of diabetic hyperglycemia and inflammation$262,184
R01 · FY2006 · DE · contact PI
Nitric Oxide Defense Against Porphyromonas gingivalis$147,361
K22 · FY2006 · DE · contact PI
In vivo study of diabetic hyperglycemia and inflammation$268,494
R01 · FY2005 · DE
Nitric Oxide Defense Against Porphyromonas gingivalis$143,068
K22 · FY2005 · DE
Nitric Oxide Defense Against Porphyromonas gingivalis$138,900
K22 · FY2004 · DE
Nitric Oxide Defense Against Porphyromonas gingivalis$134,854
K22 · FY2003 · DE